Ryman Healthcare Limited (ASX:RYM)
Australia
· Delayed Price · Currency is AUD 2.500
+0.020 (0.81%)
At close: Dec 5, 2025
Ryman Healthcare Revenue
Ryman Healthcare had revenue of 413.47M NZD in the half year ending September 30, 2025, with 24.40% growth. This brings the company's revenue in the last twelve months to 807.48M, up 12.10% year-over-year. In the fiscal year ending March 31, 2025, Ryman Healthcare had annual revenue of 759.16M with 10.41% growth.
Revenue (ttm)
807.48M NZD
Revenue Growth
+12.10%
P/S Ratio
3.58
Revenue / Employee
104.87K NZD
Employees
7,700
Market Cap
2.53B AUD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 759.16M | 71.60M | 10.41% |
| Mar 31, 2024 | 687.56M | 105.95M | 18.22% |
| Mar 31, 2023 | 581.61M | 72.86M | 14.32% |
| Mar 31, 2022 | 508.76M | 53.07M | 11.64% |
| Mar 31, 2021 | 455.69M | 32.36M | 7.64% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |